Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In Situ Identification of Putative Cancer Stem Cells by Multiplexing ALDH1, CD44, and Cytokeratin Identifies Breast Cancer Patients with Poor Prognosis

12 Mar 2010

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Cancer Genomics and Diagnostics
Share to Metastasis and carcinoma case studies

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 20228222
DOI: 10.2353/ajpath.2010.090712

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In Situ Identification of Putative Cancer Stem Cells by Multiplexing ALDH1, CD44, and Cytokeratin Identifies Breast Cancer Patients with Poor PrognosisPMID 20228222Read ↗

Moving forward in human mammary stem cell biology and breast cancer prognostication using ALDH1.Semantic proximity Read ↗

Cancer stem cell markers in breast neoplasias: their relevance and distribution in distinct molecular subtypesSemantic proximity Read ↗

Transcriptional profiles of different states of cancer stem cells in triple-negative breast cancerSemantic proximity Read ↗

Heterogeneity of normal human breast stem and progenitor cells as revealed by transcriptional profilingSemantic proximity Read ↗

Heterogeneity of Human Breast Stem and Progenitor Cells as Revealed by Transcriptional Profiling.Semantic proximity Read ↗

Breast cancer stem cells expressing different stem cell markers exhibit distinct biological characteristics.Semantic proximity Read ↗

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.Semantic proximity Read ↗

Breast Cancer Stem Cells and Tumor Heterogeneity: Characteristics and Therapeutic StrategiesSemantic proximity Read ↗

Cancer stem cells are prevalent in the basal-like 2 and mesenchymal triple-negative breast cancer subtypes in vitroSemantic proximity Read ↗

Breast Cancer Stem CellsSemantic proximity Read ↗

Biological and Molecular Heterogeneity of Breast Cancers Correlates with Their Cancer Stem Cell ContentSemantic proximity Read ↗

Cancer stem cell markers ALDH1 and CD44+/CD24- phenotype and their prognosis impact in invasive ductal carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.